JAZZ PHARMACEUTICALS PLC (JAZZ)
IE00B4Q5ZN47 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.094B 30.91% | 3.659B 18.27% | 3.834B 4.78% | 4.122B 7.51% | 4.403B 6.82% | 4.592B 4.29% | 4.874B 6.14% | 5.166B 5.99% | 5.263B 1.88% | 5.372B 2.07% | 4.983B -7.24% | |
| EBITDA YoY % growth | 951.8M 20.10% | 738.4M -22.42% | 1.317B 78.37% | 1.84B 39.70% | 1.969B 7.01% | 2.009B 2.03% | 2.327B 15.83% | 2.575B 10.66% | 2.653B 3.03% | 2.728B 2.83% | 2.437B -10.67% | |
| EBIT YoY % growth | 399.3M -22.35% | 108.9M -72.73% | 678.38M 522.94% | 1.76B 159.44% | 1.864B 5.91% | 1.916B 2.79% | 2.116B 10.44% | 2.286B 8.03% | 2.089B -8.62% | 2.07B -0.91% | 1.713B -17.25% | |
| Operating Margin | 12.90% | 2.98% | 17.69% | 42.70% | 42.33% | 41.72% | 43.41% | 44.25% | 39.69% | 38.53% | 34.38% | |
| EPS YoY % growth | 16.23 30.15% | 13.13 -19.10% | 18.32 39.53% | 20.75 13.27% | 22.24 7.19% | 22.95 3.17% | 25.82 12.54% | 27.31 5.74% | 23.18 -15.10% | 22.89 -1.28% | 16.14 -29.50% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 5.88 17.22% | 4.54 69.31% | 5.38 1.54% | 5.89 -10.84% | 6.15 4.47% |
| Revenue Q2Q % growth | 1.08B 6.73% | 1.007B 11.64% | 1.082B 5.68% | 1.117B 5.88% | 1.174B 8.70% |
| EBITDA Q2Q % growth | 492.74M -38.28% | 444.01M 79.19% | 500.51M -4.82% | 519.18M -30.95% | 559.27M 13.50% |
| EBIT Q2Q % growth | 454.84M 184.99% | 383.15M 353.93% | 454.35M 127.81% | 483.98M 86.00% | 549.63M 20.84% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 6.61 36.57% | 5.61 | 1.00 | 17.85% |
| Q2 2024 Q2Q % growth | 5.30 17.52% | 4.87 | 0.43 | 8.88% |
| Q1 2024 Q2Q % growth | 2.68 -32.15% | 4.26 | -1.58 | -37.13% |
| Q4 2023 Q2Q % growth | 5.02 7,271.43% | 5.29 | -0.27 | -5.07% |
| Q3 2023 Q2Q % growth | 4.84 -6.38% | 5.03 | -0.19 | -3.79% |
| Q2 2023 Q2Q % growth | 4.51 4.88% | 4.52 | -0.01 | -0.23% |
| Q1 2023 Q2Q % growth | 3.95 5.90% | 4.32 | -0.37 | -8.66% |
| Q4 2022 Q2Q % growth | -0.07 -101.66% | 0.33 | -0.40 | -121.41% |
| Q3 2022 Q2Q % growth | 5.17 23.10% | 4.75 | 0.42 | 8.75% |
| Q2 2022 Q2Q % growth | 4.30 10.26% | 4.28 | 0.02 | 0.58% |
| Q1 2022 Q2Q % growth | 3.73 -4.85% | 3.92 | -0.19 | -4.77% |
| Q4 2021 Q2Q % growth | 4.21 5.25% | 3.72 | 0.49 | 13.31% |
| Q3 2021 Q2Q % growth | 4.20 -2.55% | 3.38 | 0.82 | 24.08% |
| Q2 2021 Q2Q % growth | 3.90 5.12% | 3.50 | 0.40 | 11.45% |
| Q1 2021 Q2Q % growth | 3.92 771.11% | 3.79 | 0.13 | 3.53% |
| Q4 2020 Q2Q % growth | 4.00 -9.50% | 4.29 | -0.29 | -6.69% |
| Q3 2020 Q2Q % growth | 4.31 5.12% | 4.16 | 0.15 | 3.67% |
| Q2 2020 Q2Q % growth | 3.71 -8.40% | 3.17 | 0.54 | 16.86% |
| Q1 2020 Q2Q % growth | 0.45 -87.74% | 0.69 | -0.24 | -34.35% |
| Q4 2019 Q2Q % growth | 4.42 21.43% | 4.20 | 0.22 | 5.16% |
| Q3 2019 Q2Q % growth | 4.10 14.53% | 3.67 | 0.43 | 11.81% |
| Q2 2019 Q2Q % growth | 4.05 16.05% | 3.64 | 0.41 | 11.18% |
| Q1 2019 Q2Q % growth | 3.67 23.15% | 3.22 | 0.45 | 13.89% |
| Q4 2018 Q2Q % growth | 3.64 | 3.08 | 0.56 | 18.26% |
| Q3 2018 Q2Q % growth | 3.58 | 3.39 | 0.19 | 5.72% |
| Q2 2018 Q2Q % growth | 3.49 | 3.29 | 0.20 | 6.02% |
| Q1 2018 Q2Q % growth | 2.98 | 2.84 | 0.14 | 5.09% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.055B 8.52% | 1.057B | -2.031M | -0.19% |
| Q2 2024 Q2Q % growth | 1.024B 6.95% | 1.024B | -175K | -0.02% |
| Q1 2024 Q2Q % growth | 901.983M 1.03% | 972.97M | -70.987M | -7.30% |
| Q4 2023 Q2Q % growth | 1.012B 4.10% | 1.021B | -9.065M | -0.89% |
| Q3 2023 Q2Q % growth | 972.14M 3.34% | 985.21M | -13.07M | -1.33% |
| Q2 2023 Q2Q % growth | 957.317M 2.62% | 961.72M | -4.403M | -0.46% |
| Q1 2023 Q2Q % growth | 892.812M 9.72% | 913.34M | -20.528M | -2.25% |
| Q4 2022 Q2Q % growth | 972.1M 8.41% | 995.11M | -23.01M | -2.31% |
| Q3 2022 Q2Q % growth | 940.7M 12.24% | 957.84M | -17.14M | -1.79% |
| Q2 2022 Q2Q % growth | 932.9M 24.09% | 922.3M | 10.6M | 1.15% |
| Q1 2022 Q2Q % growth | 813.7M 33.92% | 869.81M | -56.11M | -6.45% |
| Q4 2021 Q2Q % growth | 896.7M 34.74% | 881.51M | 15.19M | 1.72% |
| Q3 2021 Q2Q % growth | 838.1M 39.47% | 849.17M | -11.07M | -1.30% |
| Q2 2021 Q2Q % growth | 751.8M 33.68% | 754.36M | -2.56M | -0.34% |
| Q1 2021 Q2Q % growth | 607.6M 13.63% | 620.41M | -12.81M | -2.06% |
| Q4 2020 Q2Q % growth | 665.5M 14.41% | 652.34M | 13.16M | 2.02% |
| Q3 2020 Q2Q % growth | 600.9M 11.75% | 589.13M | 11.77M | 2.00% |
| Q2 2020 Q2Q % growth | 562.4M 5.30% | 514.75M | 47.65M | 9.26% |
| Q1 2020 Q2Q % growth | 534.7M 5.21% | 555.44M | -20.74M | -3.73% |
| Q4 2019 Q2Q % growth | 581.7M 22.08% | 573.26M | 8.44M | 1.47% |
| Q3 2019 Q2Q % growth | 537.7M 14.55% | 534.88M | 2.82M | 0.53% |
| Q2 2019 Q2Q % growth | 534.1M 6.71% | 518.79M | 15.31M | 2.95% |
| Q1 2019 Q2Q % growth | 508.2M 14.30% | 475.27M | 32.93M | 6.93% |
| Q4 2018 Q2Q % growth | 476.5M | 468.92M | 7.58M | 1.62% |
| Q3 2018 Q2Q % growth | 469.4M | 492.28M | -22.88M | -4.65% |
| Q2 2018 Q2Q % growth | 500.5M | 479.28M | 21.22M | 4.43% |
| Q1 2018 Q2Q % growth | 444.6M | 442.86M | 1.74M | 0.39% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -0.01% | 0.88% | 3.84% |
| Revenue | 0% | -3.31% | 0.07% | 0.07% |